Asia Pacific Blood Plasma Derivatives Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Blood Plasma Derivatives Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Blood Plasma Derivatives Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Blood Plasma Derivatives Market Regional Analysis

6.2 Asia Pacific Blood Plasma Derivatives Market Revenue 2020-2028 (US$ Million)

6.3 Asia Pacific Blood Plasma Derivatives Market Forecast Analysis

7. Asia Pacific Blood Plasma Derivatives Market Analysis – by Type

7.1 Albumin

7.1.1 Overview
7.1.2 Albumin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Factor VIII

7.2.1 Overview
7.2.2 Factor VIII: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Factor IX

7.3.1 Overview
7.3.2 Factor IX: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Immunoglobulin

7.4.1 Overview
7.4.2 Immunoglobulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.5 Hyperimmune Globulin

7.5.1 Overview
7.5.2 Hyperimmune Globulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia Pacific Blood Plasma Derivatives Market Analysis – by Application

8.1 Hemophilia

8.1.1 Overview
8.1.2 Hemophilia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Hypogammaglobulinemia

8.2.1 Overview
8.2.2 Hypogammaglobulinemia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Immunodeficiency Diseases

8.3.1 Overview
8.3.2 Immunodeficiency Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 von Willebrand's Diseases

8.4.1 Overview
8.4.2 von Willebrand's Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Asia Pacific Blood Plasma Derivatives Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Clinics: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Asia Pacific Blood Plasma Derivatives Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Blood Plasma Derivatives Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 China: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Type
10.2.1.1.2 China: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Application
10.2.1.1.3 China: Asia Pacific Blood Plasma Derivatives Market Breakdown, by End User

10.2.1.2 India: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 India: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Type
10.2.1.2.2 India: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Application
10.2.1.2.3 India: Asia Pacific Blood Plasma Derivatives Market Breakdown, by End User

10.2.1.3 Japan: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Type
10.2.1.3.2 Japan: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Application
10.2.1.3.3 Japan: Asia Pacific Blood Plasma Derivatives Market Breakdown, by End User

10.2.1.4 Australia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Type
10.2.1.4.2 Australia: Asia Pacific Blood Plasma Derivatives Market Breakdown, by Application
10.2.1.4.3 Australia: Asia Pacific Blood Plasma Derivatives Market Breakdown, by End User

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Blood Plasma Derivatives Market Breakdown, by Type
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Blood Plasma Derivatives Market Breakdown, by Application
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Blood Plasma Derivatives Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Grifols SA

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 SK Plasma Co Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Octapharma AG

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Monobind Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Intas Pharmaceuticals Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Takeda Pharmaceutical Co Ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 CSL Behring LLC

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 LFB SA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Kedrion SpA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Fusion Health Care Pvt Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Blood Plasma Derivatives Market

Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)